Filing Details
- Accession Number:
- 0001209191-12-008686
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-09 16:09:15
- Reporting Period:
- 2012-02-08
- Filing Date:
- 2012-02-09
- Accepted Time:
- 2012-02-09 16:09:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1349077 | Lisa Kelly | C/O Vertex Pharmaceuticals Incorporated 130 Waverly St Cambridge MA 02139 | Svp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-02-08 | 8,133 | $36.80 | 28,575 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,667 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $36.80 (range $36.50 to $37.25).
- Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.